The ephrins and Eph receptors in angiogenesis. Cheng N, Brantley DM, Chen J (2002) Cytokine Growth Factor Rev 13: 75-85 Eph Receptor Tyrosine Kinases in Tumor Immunity. Shiuan E, Chen J (2016) Cancer Res 76: 6452-6457 Eph receptors and Ephrins in cancer: common themes and controversies. Chen J, Zhuang G, Frieden L, Debinski W (2008) Cancer Res 68: 10031-3 Ephrin-A1 facilitates mammary tumor metastasis through an angiogenesis-dependent mechanism mediated by EphA receptor and vascular endothelial growth factor in mice. Brantley-Sieders DM, Fang WB, Hwang Y, Hicks D, Chen J (2006) Cancer Res 66: 10315-24 Regulation of tumor initiation and metastatic progression by Eph receptor tyrosine kinases. Chen J (2012) Adv Cancer Res 114: 1-20 Impaired tumor microenvironment in EphA2-deficient mice inhibits tumor angiogenesis and metastatic progression. Brantley-Sieders DM, Fang WB, Hicks DJ, Zhuang G, Shyr Y, Chen J (2005) FASEB J 19: 1884-6 Identification of genes and pathways involved in retinal neovascularization by microarray analysis of two animal models of retinal angiogenesis. Recchia FM, Xu L, Penn JS, Boone B, Dexheimer PJ (2010) Invest Ophthalmol Vis Sci 51: 1098-105 Eph receptor tyrosine kinases in tumor and tumor microenvironment. Brantley-Sieders D, Schmidt S, Parker M, Chen J (2004) Curr Pharm Des 10: 3431-42 Reverse endocytosis of transmembrane ephrin-B ligands via a clathrin-mediated pathway. Parker M, Roberts R, Enriquez M, Zhao X, Takahashi T, Pat Cerretti D, Daniel T, Chen J (2004) Biochem Biophys Res Commun 323: 17-23 Ephrin-Eph signaling as a potential therapeutic target for the treatment of myocardial infarction. O'Neal WT, Griffin WF, Dries-Devlin JL, Kent SD, Chen J, Willis MS, Virag JA (2013) Med Hypotheses 80: 738-44
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.